A new surgical approach for the treatment of Rhinophyma
Paola Bonavolontà 1, Dell’Aversana Giovanni 1, Federica Goglia 1, Antonio Romano 1, Vincenzo Abbate 1, Antonio Arena 1, Giorgio Iaconetta 2, Luigi Califano 1
Affiliations
Article Info
1 Department of Neurosciences, Maxillofacial Surgery Unit, Reproductive and Odontostomatological Sciences, University “Federico II”, Naples, Italy
2 Department of Neurosurgery, University of Salerno, Salerno
Abstract
BACKGROUND: Rhinophyma is a rare and benign pathological condition affecting the nose. It can be localized or generalized causing a nasal deformity, mainly of the lower 2/3 of the nose. Clinically, rhinophyma is characterized by the aberrant development of the vascularization of the skin of the nose. The nose becomes particularly sensitive, and even a minimal external trauma can cause bleeding. Different treatment methods have been described during the last few years, but surgery still remains the gold standard. The aim is to obtain a reduction of the abnormal tissue, by debulking and fine contouring followed by hemostasis and a very careful postoperative care. Herein we report one case of Rhinophyma treated with the Microdebrider (Storz®). CASE REPORT: A 70 year old male with a diagnosis of rhinophyma was admitted to the Department of Maxillo-Facial Surgery of “Federico II” University of Naples. The patient underwent a debridment of rhinophyma, combining dermabrasion and decortication, using a Microdebrider (Storz®). After the surgery, the wound was covered with an advanced dressing, a collagen sponge equina (Condress®) applied at the end of the procedure and routinely during the follow up control to promote the healing process. CONCLUSION: After 2 months the patient was completely healed without any complications and without any signs of recurrence, obtaining a good aesthetic and functional result. After 25 months of follow up the result is still stable.
Keywords
- Rhinophyma
- Microdebrider
